PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
31,077,479
Share change
+4,773,152
Total reported value
$291,780,527
Put/Call ratio
314%
Price per share
$9.39
Number of holders
93
Value change
+$45,983,284
Number of buys
53
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q4 2014

As of 31 Dec 2014, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,077,479 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, Broadfin Capital, LLC, KENNEDY CAPITAL MANAGEMENT, INC., BlackRock Fund Advisors, WALL STREET ASSOCIATES, venBio Select Advisor LLC, ORBIMED ADVISORS LLC, BlackRock Institutional Trust Company, N.A., and BANK OF MONTREAL /CAN/. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.